259 related articles for article (PubMed ID: 24398105)
1. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
[TBL] [Abstract][Full Text] [Related]
2. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
Martínez-Laorden E; Hurle MA; Milanés MV; Laorden ML; Almela P
J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.
Martínez-Laorden E; García-Carmona JA; Baroja-Mazo A; Romecín P; Atucha NM; Milanés MV; Laorden ML
Br J Pharmacol; 2014 Feb; 171(3):688-700. PubMed ID: 24490859
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
Navarro-Zaragoza J; Laorden ML; Milanés MV
Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
[TBL] [Abstract][Full Text] [Related]
5. CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.
Navarro-Zaragoza J; Núñez C; Ruiz-Medina J; Laorden ML; Valverde O; Milanés MV
Br J Pharmacol; 2011 Feb; 162(4):851-62. PubMed ID: 20973778
[TBL] [Abstract][Full Text] [Related]
6. Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc).
Almela P; Navarro-Zaragoza J; García-Carmona JA; Mora L; Hidalgo J; Milanés MV; Laorden ML
PLoS One; 2012; 7(10):e47089. PubMed ID: 23071721
[TBL] [Abstract][Full Text] [Related]
7. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
Navarro-Zaragoza J; Núñez C; Laorden ML; Milanés MV
Mol Pharmacol; 2010 May; 77(5):864-73. PubMed ID: 20159948
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
Almela P; Victoria Milanés M; Luisa Laorden M
Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
[TBL] [Abstract][Full Text] [Related]
9. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.
Skelton KH; Oren D; Gutman DA; Easterling K; Holtzman SG; Nemeroff CB; Owens MJ
Eur J Pharmacol; 2007 Sep; 571(1):17-24. PubMed ID: 17610870
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
11. Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats.
Laorden ML; Castells MT; Milanés MV
Br J Pharmacol; 2002 May; 136(1):67-75. PubMed ID: 11976269
[TBL] [Abstract][Full Text] [Related]
12. Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal.
Almela P; Milanés MV; Laorden ML
Br J Pharmacol; 2007 Jul; 151(6):787-97. PubMed ID: 17549049
[TBL] [Abstract][Full Text] [Related]
13. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala.
Martínez-Laorden E; Navarro-Zaragoza J; Milanés MV; Laorden ML; Almela P
Addict Biol; 2020 Jul; 25(4):e12792. PubMed ID: 31282111
[TBL] [Abstract][Full Text] [Related]
14. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between protein kinase A and mitogen-activated protein kinases signalling in the adaptive changes observed during morphine withdrawal in the heart.
Almela P; Atucha NM; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 2009 Sep; 330(3):771-82. PubMed ID: 19567779
[TBL] [Abstract][Full Text] [Related]
16. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
[TBL] [Abstract][Full Text] [Related]
18. Naloxone-precipitated morphine withdrawal evokes phosphorylation of heat shock protein 27 in rat heart through extracellular signal-regulated kinase.
Almela P; Martínez-Laorden E; Atucha NM; Milanés MV; Laorden ML
J Mol Cell Cardiol; 2011 Jul; 51(1):129-39. PubMed ID: 21530534
[TBL] [Abstract][Full Text] [Related]
19. Induction of FosB/DeltaFosB in the brain stress system-related structures during morphine dependence and withdrawal.
Núñez C; Martín F; Földes A; Luisa Laorden M; Kovács KJ; Victoria Milanés M
J Neurochem; 2010 Jul; 114(2):475-87. PubMed ID: 20438612
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
